NewSold out
Botulax 50 iu -  Type A, HUGELPHARMA S. Korea
Botulax 50 iu -  Type A, HUGELPHARMA S. Korea
Botulax 50 iu -  Type A, HUGELPHARMA S. Korea
Botulax 50 iu -  Type A, HUGELPHARMA S. Korea

Botulax 50 iu - Type A, HUGELPHARMA S. Korea

Delivery in 5 days
Out of stock

In Stock(0 items left )

Sale will end after

Features of our Botulinum Toxin Type A:

✔ Excellent Effect - appreciable improvement as a result
✔ Simple Procedure - just a few tiny injections
✔ Short Procedure - 10 minutes, as short as a tea break
✔ No Down Time - resume your usual routines right away
✔ Fast Onset- takes only 2 to 3 days to see noticeable effect
✔ Outstanding Efficacy - over 98% users are satisfied with the Botulax® treatments
✔ Safety of Botulinum Toxin Type A is proved and verified in comparison to Onabotulinumtoxina in clinical studies.
✔ Global Product - Botulinum Toxin Type A is being sold in over 25 countries.
✔ Guaranteed Safety - Approved by Health Authorities with over 10 years' clinical practices.




Botulinum Toxin type A comes in dosage units of 50, 100 and 200. Each vial contains the active ingredient, Clostridium botulinum toxin type A 50 units (U), stabilizer: Human serum albumin 0.25mg and Sodium chloride (EP) 0.45mg.




Not just cosmetic Botox, Botulinum Toxin Type A also has therapeutic applications. Botulinum Toxin Type A is used for the treatment of benign essential blepharospasm in patients of 18 years of age and above. For the treatment of equinus foot deformity due to spasticity in pediatric cerebral palsy in patients of 2 years of age and above. And as it is known, Botox is also used for temporary improvement of serious glabellar wrinkles ranging from moderate to severe, associated with corrugator muscle and/or procerus muscle activities in adults over the age of 18 and below the age of 65. The vials are generally stored in a freezer or refrigerator and they retain a shelf life of 24 months.




For blepharospasm the initial recommended dose is 1.25 - 2.5 U (0.05 mL to 0.1 mL volume at each site) injected into the medial and lateral pretarsal orbicularis oculi of the upper lid and into the lateral pretarsal orbicularis oculi of the lower lid. For pediatric cerebral palsy, a total dose of 4U/kg of body weight is recommended for the affected gastrocnemius muscle in patients with hemiplegia. And in patients with diplegia, the recommended dose is 6U/kg of body weight divided between both legs. The maximum dose administered must not exceed 200U/patient at a time. For Glabellar wrinkles reconstituted sterile saline. 20U is used and there are additional application instructions for best practice, actual amounts vary on the presentation of the client.




In Blepharospasm, the effects should appear within three days and peak after three weeks.  For pediatric cerebral palsy applications, the expectation is improvement within four weeks of the injection. The effects vary for glabellar wrinkles due to the usually individualized doses.




There is a possibility of reactions at the site of an injection, and effects beyond the injection site, including but not limited to asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties.  Serious hypersensitivity has been reported as rare.  There is a caution for people with pre-existing neuromuscular disorders, and for those with corneal exposure and ulceration in blepharospasm.  Botulinum Toxin Type A is not to be administered at all if a patient has a known allergy to any of the ingredients, or if the patients have neuromuscular junctional disorders or known to have adverse reactions. They should not be administered while taking muscle relaxants and some antibiotics. Further, the actual effects of prolonged use are not entirely explored. There is also additional advice for the specific therapeutic conditions mentioned, as this description is not comprehensive.




In case of an overdose it has been advised that effects may not be immediate. It is further advised that the patient can suffer from muscle weakness and/or paralysis for a period of several weeks after the occurrence. There is an antitoxin available but the caution with the antitoxin is that it will not reduce any already apparent effects.

  • Once your product has shipped, it usually takes 4 to 6 business days in USA, 3 to 5 in Europe. 5 to 10 for the rest of the world